The Effects of Benzene and Hydroquinone on Myeloid Differentiation of HL-60 Promyelocytic Leukemia Cells

References

• Goldstein B. D. Clinical hematotoxicity of benzene. Adv. Mod. Environ. Toxicol., XVI, Benzene: Occupational and Environmental Hazards—Scientific Update, M. A. Mehlman. Princeton Scientific Publishing Co., Inc., Princeton 1989; 55–65
   Google Scholar
• Arp E. W., Checkoway H. Lymphocytic leukemia and exposures to benzene and other solvents in the rubber industry. J. Occup. Med. 1983; 25: 598–602
   PubMedGoogle Scholar
• Infante P. F., White M. C. Epidemiological observations of leukemia by cell type and adverse effects associated with low-level exposure. Environ. Health Perspect. 1983; 52: 75–82
   PubMed Web of Science ®Google Scholar
• Aksoy M. Malignancies due to occupational exposure to benzene. Am. J. Ind. Med. 1985; 7: 395–402
   PubMed Web of Science ®Google Scholar
• Sammett D., Lee E. W., Kocsis J. J., Snyder R. Partial hepatectomy reduces both metabolism and toxicity of benzene. J. Toxicol. Environ. Health. 1979; 5: 785–792
   PubMed Web of Science ®Google Scholar
• Tunek A., Platt K. L., Przybylski M., Oesch F. Multi-step metabolic activation of benzene. Effect of super-oxide dismutase on covalent binding to microsomal macro-molecules and identification of glutathione conjugates using high pressure liquid chromatography and field desorption mass spectrometry. Chem. Bio. Interact. 1980; 33: 1–17
   PubMed Web of Science ®Google Scholar
• Rickert D. E., Baker T. S., Bus J. S., Barrow C. S., Irons R. D. Benzene disposition in the rat after exposure by inhalation. Toxicol. Appl. Pharmacol. 1979; 49: 417–423
   PubMed Web of Science ®Google Scholar
• Greenlee W. F., Gross E. A., Irons R. D. Relationship between benzene toxicity and the disposition of 14C-labeled benzene in the rat. Chem. Biol. Interact. 1981; 33: 285–299
   PubMed Web of Science ®Google Scholar
• Schlosser M. J., Kalf G. F. Metabolic activation of hydroquinone by macrophage peroxidase. Chem. Biol. Interact. 1989; 72: 191–207
   PubMed Web of Science ®Google Scholar
• Smith M. T., Yager J. W., Steinmetz K. L., Eastmond D. A. Peroxidase-dependent metabolism of benzene's phenolic metabolites and its potential role in benzene toxicity and carcinogenicity. Environ. Health Perspect. 1989; 82: 23–29
   PubMed Web of Science ®Google Scholar
• Kalf G. F. Recent advances in the metabolism and toxicity of benzene. CRC Crit. Rev. Toxicol. 1987; 18: 141–159
   Web of Science ®Google Scholar
• Dean B. J. Recent findings on the genetic toxicology of benzene. Mutation Res. 1985; 154: 153–181
   PubMed Web of Science ®Google Scholar
• Dempster A. M., Snyder C. A. Short term benzene exposure provides a growth advantage for granulopoietic progenitor cells over erythroid progenitor cells. Arch. Toxicol. 1990; 64: 539–544
   PubMed Web of Science ®Google Scholar
• Irons R. D., Stiliman W. S., Colagiovanni D. B., Henry V. C. Synergistic action of the benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte/macrophage colony-stimulating factor in vitro. Proc. Nat. Acad. Sci. USA 1992; 89: 3691–3695
   PubMed Web of Science ®Google Scholar
• Fontana J. A., Colbert D. A., Deisseroth A. B. Identification of a population of bipotent stem cells in the HL-60 human promyelocytic leukemia cell line. Proc. Nat. Acad. Sci. USA 1981; 78: 3838–3866
   Web of Science ®Google Scholar
• Collins S. J. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation and cellular oncogene expression. Blood 1987; 70: 1233–1244
   PubMed Web of Science ®Google Scholar
• Rovera G., Santoli D., Damsky C. Human promelocytic leukemia cells in culture differentiate into macro-phage-like cells when treated with phorbol diesters. Proc. Nat. Acad. Sci. USA 1979; 76: 2779–2783
   PubMed Web of Science ®Google Scholar
• Huberman E., Callahan M. F. Induction of terminal differentiation in human promyelocytic leukemia cells by tumor promoting agents. Proc. Nat. Acad. Sci. USA 1979; 76: 1293–1297
   PubMed Web of Science ®Google Scholar
• Murao S. I., Gemmell M. A., Callahan M. F., Anderson N. L., Huberman E. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by la, 25-dihydroxyvitamin D3 and phorbol- 12-myristate-13-acetate. Cancer Res. 1983; 43: 4989–4996
   PubMed Web of Science ®Google Scholar
• Tanaka H., Abe E., Miyaura C., Shiina Y., Suda T. la, 25-Dihydroxyvitamin D3 induces differentiation of human promyelocytic cells (HL-60) into monocyte-macrophages but not into granulocytes. Biochem. Biophys. Res. Comm. 1983; 117: 86–92
   PubMed Web of Science ®Google Scholar
• McCarthy D. M., San Miguel J. F., Freake H. C., Green P. M., Zola H., Catovksy D., Goldman J. M. 1α,25-Dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukemia (HL-60) cells and induces mono-cytes-macrophages in HL-60. Leuk. Res. 1983; 7: 51–55
   PubMed Web of Science ®Google Scholar
• Breitman J. R., Seloick S. E., Collins S. J. Induction of differentiation of the human promyelocytic cell line HL-60 by retinoic acid. Proc. Nat. Acad. Sci. USA 1980; 77: 2936–2940
   PubMed Web of Science ®Google Scholar
• Tanaka Y., Tsuyuki M., Itaya-Hironaka A., Inada Y., Yoshihara K., Kamiya T. Retinoic acid-induced differentiation-specific C-kinase-dependent phosphorylation of cytosolic 44 and 32 kDa proteins in HL-60 cells. Biochem. Biophys. Res. Comm. 1990; 168: 1253–1260
   PubMed Web of Science ®Google Scholar
• Collins S. J., Ruscetti F. W., Gallagher R. E., Gallo R. C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl methyl sulfoxide (DMSO) and other polar solvents. Proc. Nat. Acad. Sci. USA 1978; 75: 2458–2462
   PubMed Web of Science ®Google Scholar
• O'Connor A., Carlson C., Kalf G. F. Differentiation of HL-60 cells to granulocytes is induced by benzene. Proc. Am. Assoc. Cancer Res. 1992; 33: 43
   Google Scholar
• O'Connor A., Kalf G. F. 1993, submitted for publication
   Google Scholar
• Aihara H., Asaoka Y., Yoshida K., Nishisuka Y. Sustained activation of protein kinase-C is essential to HL-60 cell differentiation. Proc. Nat. Acad. Sci. USA 1991; 88: 11062–11066
   PubMed Web of Science ®Google Scholar
• Nishimura M., Kaku K., Azuno Y., Okafugi K., Inoue Y., Kaneko T. Stimulation of phosphoinositol turnover and protein kinase C activation by granulocyte-macrophage colony-stimulating factor in HL-60 cells. Blood 1992; 80: 1045–1051
   PubMed Web of Science ®Google Scholar
• Roghani M., DaSilva C., Guvelli D., Castagna M. Benzene and toluene activate protein kinase C. Car-cinogenesis 1987; 8: 1105–1107
   PubMed Web of Science ®Google Scholar
• Feuerstein W. L., Cooper J. S. Rapid protein phosphorylation induced by phosphatidylethanolamine in HL-60 cells. J. Biol. Chem. 1983; 258: 10786–10793
   PubMed Web of Science ®Google Scholar
• Gullberg M., Noreus K., Brattsand G., Friedrich B., Shingler V. Purification and characterization of a 19 killodalton intracellular protein: an activation regulated putative protein kinase C substrate of T lymphocytes. J. Biol. Chem. 1990; 265: 17499–17505
   PubMed Web of Science ®Google Scholar
• Roos G., Landberg G., Brattsand G., Gullberg M. Expression of a 19 kDa protein kinase C substrate in human malignant hematopoietic cells. Proc. Am. Assoc. Cancer. Res. 1992; 33: 87
   Google Scholar
• Jones N., Lord J., Brown G. Changes in the phosphorylation status of a 19 kDa cytosolic protein are linked to growth arrest of HL-60 cells. Leuk. Res. 1992; 16: 353–361
   PubMed Web of Science ®Google Scholar
• Braverman R., Bhattacharya B., Feuerstein N., Cooper H. L. Identification and characterization of the nonphosphorylated precursor of pp17, a phosphoprotein associated with phorbol ester induction of growth arrest and mono-cytic differentiation of HL-60 promyelocytic leukemia cells. J. Biol. Chem. 1986; 261: 14342–14348
   PubMed Web of Science ®Google Scholar
• Touqui L., Rothut B., Shaw A. M., Fradin A., Vargaftig B. B., Russo-Marie F. Platelet activation. A role for 40K anti-phospholipase A2 protein indistinguishable from lipocortin. Nature 1986; 321: 177–180
   PubMed Web of Science ®Google Scholar
• Merrill A. H., Serini A. M., Stevens V. L., Hannun Y. A., Bell R. M., Kinkade J. M. Inhibition of phorbol ester-dependent differentiation of human promyelocytic leukemic (HL-60) cells by sphinganine and other long-chain bases. J. Biol. Chem. 1986; 261: 12610–12615
   PubMed Web of Science ®Google Scholar
• Miller A. M., Weiner R. S., Ziboh V. A. Evidence for the role of leukotrienes C4 and D4 as essential intermediates in CSF-stimulated human myeloid colony formation. Exp. Hematol. 1986; 14: 760–765
   PubMed Web of Science ®Google Scholar
• Ziboh V. A., Wong T., Wu M. C., Yunis A. A. Modulation of colony stimulating factor-induced murine myeloid colony formation by S-peptido-lipoxygenase products. Cancer Res. 1986; 46: 600–603
   PubMed Web of Science ®Google Scholar
• Miller A. M., Kobb S. M., McTiernan R. Regulation of HL-60 differentiation by lipoxygenase pathway metabolites in vitro. Cancer Res. 1990; 50: 7275–7260
   Google Scholar
• Snyder D. S., Castro R., Desforges J. F. 5-Li-poxygenase metabolites of archidonic acid modulate proliferation of malignant hematopoietic cell lines. Blood 1986; 70: 185a
   Google Scholar
• Miller A. M., Cullen M. K., Kobb S. M., Weiner R. S. Effects of lipoxygenase and glutathione pathway inhibitors on leukemic cell line growth. J. Lab. Clin. Med. 1989; 113: 355–361
   PubMed Web of Science ®Google Scholar
• Snyder D. S., Castro R., Desforges J. Antipro-liferative effects of lipoxygenase inhibitors on malignant human hematopoietic cell lines. Exp. Hematol. 1989; 17: 6–9
   PubMed Web of Science ®Google Scholar
• Yoshimoto T., Yokohama C, Yokoyama C, Ochi K., Yamamoto S., Maki Y., Ashida Y., Terao S., Shiraishi M. 2-(12-Hydroxy-5,10-dinyl)3,5,6-trimethyl-l,4-benzoquinone (AA861), a selective inhibitor of the 5-lipox-ygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxsis. Biochim. Biophys. Acta 1982; 713: 470–473
   PubMed Web of Science ®Google Scholar
• Jones T. R., Zamboni R., Belley M., Champion E., Charete L., Ford-Hutchinson A. W., Frennette R., Gauthier J. Y., Leger S., Masson P., McFarlane C. S., Piechuta H., Rokach L., Williams H., Young R. N. Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. Can. J. Physiol. Pharmacol. 1989; 67: 17–28
   PubMed Web of Science ®Google Scholar
• Fleisch J. H., Rinkema L. E., Haisch K. D., McCullough D., Carr F. P., Dillard R. D. Evaluation of LY163443, l-[2-hydroxy-3-propyl-4-(14-(lH-tetrazp;-5-ylm-ethyl)phenoxy]methyl) phenylethanone, as a pharmacologic antagonist of leukotrienes D4 and E4. Nauyn-Schmiedebergs Arch. Pharmacol 1986; 333: 70–77
   PubMed Web of Science ®Google Scholar
• Oliveira N. L., Kalf G. F. Induced differentiation of HL-60 promyelocytic leukemia cells to monocytes/mac-rophages is inhibited by hydroquinone, a hematotoxic metabolite of benzene. Blood 1992; 79: 627–633
   PubMed Web of Science ®Google Scholar
• Hanazawa S., Hanaizuma C., Amano S., Hirose K., Ohmori Y., Kumegawa M., Yamauri I., Kitano S. Inductive effect of recombinant human interleukin lα and β on differentiation of the macrophage cell line P388D. J. Cell Physiol. 1981; 136: 543–546
   Web of Science ®Google Scholar
• Renz J. F., Kalf G. F. Role for interleukin-1 (IL-1) in benzene-induced hematotoxicity: Inhibition of conversion of pre-IL-lα to mature cytokine in murine macrophages by hydroquinone and prevention of benzene-induced hematotoxicity in mice by IL-lα. Blood 1991; 78: 938–944
   PubMed Web of Science ®Google Scholar
• Sater R. A., Cripe L. D., Taylor J. D., Niedel J. D. Complex regulation of macrophage colony-stimulating factor on the HL-60 promyelocytic cell line. J. Immunol. 1991; 147: 633–637
   PubMed Web of Science ®Google Scholar
• Horiguchi J., Warren M. K., Kufe D. Expression of the macrophage-specific colony-stimulating factor in human monocytes treated with granulocyte-macrophage colony-stimulating factor. Blood. 1987; 69: 1259–1261
   PubMed Web of Science ®Google Scholar
• Wu J., Zhu J-Q., Han K-K., Zhu D-X. The role of the c-fms oncogene in the regulation of HL-60 cell differentiation. Oncogene 1990; 15: 873–877
   Google Scholar
• Valtieri M., Tweardy D. J., Caracciolo D., Johnson K., Mavilio F., Altman S., Santoli D., Rovera G. Cytokine-dependent granulocytic differentiation: Regulation of proliferative and differentiative responses in a murine progenitor cell line. J. Immunol. 1987; 138: 3829–3835
   PubMed Web of Science ®Google Scholar